APPL1 and Alzheimer disease: In this study, we show that Vps34 inhibition recapitulates some of the endolysosomal defects seen in early stages of AD, namely enlargement of EEA1-positive early endosomes46, stabilization of APPL1/Rab5-positive endosomes and elevated APP-CTFβ47.